If KCa3.1 blockade inhibits three key and early steps in the process of EMT in vivo, KCa3.1 blockade may not only be useful for the inhibition of lung parenchymal and airway wall fibrosis, but also the prevention of cancer progression. Here, KCNN4 is linked to cancer.